… IgM responses against S glycoprotein, RBD and N protein across the cohort did not indicate
a … to S glycoprotein, RBD and N protein, whereas singular seroconversion to N protein or S …

The Omicron lineage of SARS-CoV-2, which was first described in November 2021, spread
rapidly to become globally dominant and has split into a number of sublineages. BA.1 …

… Finally, we performed neutralization assays using sera from volunteers 4 (n = 20) and 10
weeks (n = 20) after a single dose of the Pfizer-BioNTech vaccine. In the United Kingdom, for …

The Omicron, or Pango lineage B.1.1.529, variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) carries multiple spike mutations with high transmissibility and …

The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
critical for virus infection through the engagement of the human ACE2 protein 1 and is a major …

Serological techniques commonly used to quantify influenza-specific antibodies include the
Haemagglutination Inhibition (HI), Single Radial Haemolysis (SRH) and Virus Neutralization …

The isolation of broadly neutralizing antibodies against influenza A viruses has been a long-sought
goal for therapeutic approaches and vaccine design. Using a single-cell culture …

… In this instance, the vector originates from pCI G3 N, B, or NB, which are differentially restricted
in certain murine cells based on the mouse resistant gene alleles Fv1 N and Fv1 B (42). …

… In control groups, 113 high-risk health care workers from South China (n = 62) and North China
(n = … In brief, 61 and 89% of patients were treated with steroids in South and North China, …

… Early samples (n = 12) were taken %14 days from symptom onset (median 13 days); later
samples (n = 16) were taken R21 days following symptom onset (median 38 days). All cases …